$140M Verdict Against AbbVie In Testosterone MDL Tossed

Law360 (July 5, 2018, 5:50 PM EDT) -- An Illinois federal judge vacated a $140 million verdict against AbbVie Inc. from the second bellwether in multidistrict litigation over testosterone products on Thursday, saying the jury’s finding for the company on the case’s strict liability claim threw a wrench in the rest of its verdict.

U.S. District Judge Matthew Kennelly agreed with the Illinois-based pharmaceutical company that the jury’s finding for AbbVie on strict liability at the end of the October trial clashed with its finding for plaintiff Jeffrey Konrad on his negligence claim. He vacated the judgment and ordered a new trial on all claims, saying the inconsistency required...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents



Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Illinois Northern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)


Subscribers Only

Date Filed

March 14, 2014

Law Firms


Government Agencies

Judge Analytics